MedPath

Assessment of the Optimal Amount of Proteins at Breakfast for Children

Not Applicable
Completed
Conditions
Healthy Children
Interventions
Other: Protein-based beverage
Registration Number
NCT02465151
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

The primary objective of this trial is to identify how much protein is required at breakfast to promote positive whole body protein balance over the following 9h period.

Detailed Description

This study will be the first to establish the role of eating protein at breakfast on whole body protein balance in healthy children.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Aged between 7-12 years of age
  • Healthy and recreationally physically active (obtaining a 3- day average moderate/vigorous physical activity of at least 30 min/day)
  • Body mass at ≥10th percentile for 7 year olds and ≤85th percentile for 12 year olds. Values based upon 2000 CDC Growth Charts for the United States
  • Having obtained his/her informed assent
  • Having obtained his/her consent from parent or legal guardian
  • Being able to communicate in local language
  • Have a habitual daily protein consumption of between 1.6 g/kg and 2.4 g/kg/bw
Exclusion Criteria
  • Self-report on regular medication impacting the metabolism, such as corticoids, hormone (e.g thyroid, adrenal) treatment, or medication against diabetes or against hypercholesterolemia or hypertriglyceridemia
  • Self-reported history of metabolic, hepatic or renal disease
  • Self-reported allergy to milk proteins (e.g., whey or casein) or intolerance to any food ingredients to be used in the study products and meals
  • Within 1.5 years of estimated age of peak height velocity (PHV)
  • Special diet or weight loss program (e.g Atkins diet)
  • Consuming breakfast containing more than 21g of protein on each day of the 3-d screening period
  • Subject who cannot be expected to comply with the study procedures, including unwillingness to consume study product and meals
  • Currently participating or having participated in another nutritional-clinical trial during the last 2 months prior to the beginning of this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low ProteinProtein-based beverage-
High ProteinProtein-based beverage-
No ProteinProtein-based beverage-
Medium ProteinProtein-based beverage-
Primary Outcome Measures
NameTimeMethod
Whole body protein balance (g protein/9 hours) by nitrogen balance technique9 hours following ingestion of investigational product
Secondary Outcome Measures
NameTimeMethod
Whole body protein balance (g protein/24 hours) by nitrogen balance technique24 hours following ingestion of investigational product

Trial Locations

Locations (1)

Goldring Centre for High Performance Sport at University of Toronto

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath